Jeroen M. Cornelissen
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 114 publications
NFкB pathway suppression as a key driver of pacritinib response in high-risk myelofibrosis.
Journal: British journal of haematology
Published: May 12, 2026
Correction: Pacritinib in transplant-eligible myelofibrosis: final analysis of the phase II HOVON-134 trial.
Journal: Bone marrow transplantation
Published: May 05, 2026
Pacritinib in transplant-eligible myelofibrosis: final analysis of the phase II HOVON-134 trial.
Journal: Bone marrow transplantation
Published: October 20, 2025
Pacritinib in transplant-eligible myelofibrosis: final analysis of the phase II HOVON-134 trial.
Journal: Bone marrow transplantation
Published: October 20, 2025
Jeroen Cornelissen retires as Editor-in-Chief.
Journal: Journal of materials chemistry. B
Published: December 18, 2024
Folding of mRNA-DNA Origami for Controlled Translation and Viral Vector Packaging.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: November 14, 2024
Treatment-Free Remission Outcomes in a BCR::ABL1 Digital PCR Selected Clinical Cohort of CML Patients.
Journal: European journal of haematology
Published: August 25, 2024
Looking back at the 10th anniversary year of Journal of Materials Chemistry A, B and C.
Journal: Journal of materials chemistry. B
Published: December 12, 2023
An approach for state differentiation in nucleic acid circuits: Application to diagnostic DNA computing.
Journal: Analytica chimica acta
Published: September 09, 2023
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT.
Journal: American journal of hematology
Published: August 06, 2023
Last Updated: 09/26/2026